Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
patients
100%
cardiovascular diseases
100%
design
100%
biological markers
100%
diseases
75%
risks
75%
arteries
50%
coronaries
50%
data
25%
validation
25%
values
25%
symptoms
25%
clinical trials
25%
blood cells
25%
populations
25%
monocytes
25%
pathogenesis
25%
messenger-rna
25%
proteins
25%
organs
25%
prediction
25%
signals
25%
indicators
25%
lymphocytes
25%
atherosclerosis
25%
grants
25%
plasma
25%
life styles
25%
granulocytes
25%
Keyphrases
Cardiovascular Disease
100%
Circulating Cells
100%
Secondary Risk
50%
Adverse Events
25%
Pathophysiology
25%
Monocytes
25%
Active Role
25%
Predictive Value
25%
Platelets
25%
Coronary Artery Disease
25%
Granulocytes
25%
Disease Progression
25%
Novel Biomarkers
25%
MicroRNA
25%
T Cells
25%
Serum Markers
25%
Disease Symptoms
25%
Blood Cells
25%
Risk Markers
25%
Disease States
25%
Patients with Coronary Artery Disease
25%
Non-modifiable Risk Factors
25%
Risk Prediction
25%
Bioinformatics
25%
Medical History
25%
Biomarker Discovery
25%
Omics Approaches
25%
Clinical Trial Design
25%
Expression Profile
25%
Cellular Effectors
25%
Biological Specimens
25%
Clinical Profile
25%
Flow Cytometric
25%
Cell Fraction
25%
High-throughput Omics
25%
Study Grants
25%
Secreted Biomarkers
25%
Individual Treatment Trials
25%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Hemocyte
100%
Biomarker Discovery
100%
T Cell
100%
Clinical Trial Design
100%
Tamsulosin
100%
Platelet
100%
Blood Plasma
100%
Messenger RNA
100%
Polymorphonuclear Cell
100%
Bioinformatics
100%
Medicine and Dentistry
Biological Marker
100%
Cardiovascular Disease
100%
Coronary Artery Disease
50%
Adverse Event
25%
Pathophysiology
25%
microRNA
25%
Atherosclerosis
25%
Platelet
25%
T Lymphocyte
25%
Medical History
25%
Disease Exacerbation
25%
Blood Cell
25%
Granulocyte
25%
Tamsulosin
25%
Clinical Trial Design
25%
Messenger RNA
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Cardiovascular Disease
100%
Coronary Artery Disease
50%
Pathophysiology
25%
Adverse Event
25%
Disease Exacerbation
25%
Atherosclerosis
25%
Tamsulosin
25%
microRNA
25%
Medical History
25%
Clinical Trial Design
25%
Messenger RNA
25%
Diseases
25%
Immunology and Microbiology
Coronary Artery
100%
Blood Plasma
50%
Platelet
50%
Atherosclerosis
50%
T Cell
50%
Hemocyte
50%
Granulocyte
50%
Bioinformatics
50%